Robin Weaver

1.6k total citations · 1 hit paper
6 papers, 1.2k citations indexed

About

Robin Weaver is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Robin Weaver has authored 6 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Robin Weaver's work include Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Robin Weaver is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Robin Weaver collaborates with scholars based in United States. Robin Weaver's co-authors include Antonio J Grillo-López, Christine A. White, Myron S. Czuczman, Brian K. Link, Thomas A. Davis, Ronald Levy, Baha Alkuzweny, Peter McLaughlin, J. Rosenberg and David G. Maloney and has published in prestigious journals such as Journal of Clinical Oncology, Annual Review of Medicine and Leukemia & lymphoma.

In The Last Decade

Robin Weaver

6 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

2000 523 citations Thomas A. Davis, Antonio J Grillo-López et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Weaver United States	6	800	535	460	417	267	6	1.2k
Manali Kamdar United States	17	818 1.0×	1.1k 2.0×	286 0.6×	157 0.4×	211 0.8×	90	1.4k
Wolfram Jung Germany	17	823 1.0×	821 1.5×	379 0.8×	401 1.0×	489 1.8×	41	1.7k
Jocelyn Maragulia United States	16	993 1.2×	581 1.1×	325 0.7×	112 0.3×	287 1.1×	37	1.3k
Juan Pablo Alderuccio United States	13	538 0.7×	487 0.9×	159 0.3×	131 0.3×	99 0.4×	79	749
Klaus Willenbrock Germany	16	558 0.7×	465 0.9×	198 0.4×	57 0.1×	291 1.1×	23	874
Lawrence D. Durack United States	13	711 0.9×	443 0.8×	147 0.3×	761 1.8×	165 0.6×	19	1.3k
A H Goldstone United Kingdom	10	502 0.6×	405 0.8×	245 0.5×	121 0.3×	178 0.7×	23	1.0k
Jeff Wiezorek United States	8	743 0.9×	1.4k 2.6×	181 0.4×	76 0.2×	281 1.1×	21	1.6k
Craig A. Portell United States	16	409 0.5×	322 0.6×	281 0.6×	55 0.1×	156 0.6×	65	765
DA Carson United States	13	558 0.7×	288 0.5×	881 1.9×	92 0.2×	426 1.6×	16	1.3k

Countries citing papers authored by Robin Weaver

Since Specialization

Citations

This map shows the geographic impact of Robin Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Weaver more than expected).

Fields of papers citing papers by Robin Weaver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Weaver. The network helps show where Robin Weaver may publish in the future.

Co-authorship network of co-authors of Robin Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Weaver. A scholar is included among the top collaborators of Robin Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Weaver. Robin Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Epstein, Michael H., Marc S. Atkins, Douglas Cullinan, Krista Kutash, & Robin Weaver. (2008). Reducing Behavior Problems in the Elementary School Classroom. IES Practice Guide. NCEE 2008-012.. 19 indexed citations

2.

Czuczman, M. S., et al.. (2006). Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab. Leukemia & lymphoma. 47(9). 1830–1840. 23 indexed citations

3.

Czuczman, Myron S., et al.. (2004). Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up. Journal of Clinical Oncology. 22(23). 4711–4716. 265 indexed citations

4.

White, Christine A., Robin Weaver, & Antonio J Grillo-López. (2001). Antibody-Targeted Immunotherapy for Treatment of Malignancy. Annual Review of Medicine. 52(1). 125–145. 103 indexed citations

5.

Davis, Thomas A., Antonio J Grillo-López, Christine A. White, et al.. (2000). Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment. Journal of Clinical Oncology. 18(17). 3135–3143. 523 indexed citations breakdown →

6.

Davis, Thomas A., Christine A. White, A.J. Grillo-López, et al.. (1999). Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab. Journal of Clinical Oncology. 17(6). 1851–1851. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact